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Abstract
Background: Molecular epidemiology of Mycobacterium tuberculosis, its transmission dynamics and population
structure have become important determinants of targeted tuberculosis control programs. Here we describe recent
changes in the distribution of M. tuberculosis genotypes in New South Wales (NSW), Australia and compared strain
types with drug resistance, site of disease and demographic data.
Methods: We evaluated all culture-confirmed newly identified tuberculosis cases in NSW, Australia, from 2010-2012.
M. tuberculosis population structure and clustering rates were assessed using 24-loci Mycobacterial interspersed
repetitive unit (MIRU) analysis and compared to MIRU data from 2006-2008.
Results: Of 1177 tuberculosis cases, 1128 (95.8%) were successfully typed. Beijing and East African Indian (EAI)
lineage strains were most common (27.6% and 28.5%, respectively) with EAI strains increasing in relative abundance
from 11.8% in 2006-2008 to 28.5% in 2010-2012. Few cases of multi-drug resistant tuberculosis were identified
(18; 1.7%). Compared to 12-loci, 24-loci MIRU provided improved cluster resolution with 695 (61.6%) and 227
(20.1%) clustered cases identified, respectively. Detailed analysis of the largest cluster identified (an 11 member
Beijing cluster) revealed wide geographic diversity in the absence of documented social contact.
Conclusions: EAI strains of M. tuberculosis recently overtook Beijing family as a prevalent cause of tuberculosis in
NSW, Australia. This lineage appeared to be less commonly related to multi-drug resistant tuberculosis as compared
to Beijing strain lineage. The resolution provided by 24-loci MIRU typing was insufficient for reliable assessment of
transmissions, especially of Beijing family strains.
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Background
Globally, tuberculosis remains a major cause of disease
and untimely death. In 2011, there were an estimated
8.8 million incident cases and 1.8 million deaths attrib-
uted to tuberculosis [1]. Although the global tuberculosis
incidence rate has been declining at ~2% per year since
2002, the impact of control efforts remains limited in
areas affected by poverty, human immunodeficiency
virus infection or drug resistance in Mycobacterium
tuberculosis [1,2]. In non-endemic areas such as Australia
disease rates remain low, but progress towards tuberculosis
elimination is limited. In fact, the rate of bacteriologically
confirmed tuberculosis in Australia has gradually risen
from 3.7/100,000 in 1998 to 4.9/100,000 in 2009 [3].
The state of New South Wales (NSW) report the
highest absolute number of tuberculosis cases within
Australia, but disease rates are highly variable [4]. NSW
surveillance data indicate that the majority of tubercu-
losis cases identified occur among recent immigrants
who acquired M. tuberculosis infection in their country
of origin [5]. Tuberculosis incidence rates in excess of
60/100,000 in parts of metropolitan Sydney represent
concentrated pockets of imported disease, which may
support local transmission [6] .The NSW Mycobacterial
Reference Laboratory (MRL) provides ongoing laboratory
surveillance to help identify local tuberculosis outbreaks
and guide public health responses. Since 2006, the labora-
tory performed routine strain typing using mycobacterial
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interspersed repetitive unit (MIRU) analysis to describe the
M. tuberculosis population structure and detect local trans-
mission events. MIRU typing identifies variable number
tandem repeats found in 41 loci across the M. tuberculosis
genome [7]. Its discriminatory power varies depending on
the M. tuberculosis population structure and the number of
loci used, for example 24-loci MIRU is more discriminatory
than 12 and 15-loci MIRU [8,9].
An assessment of new tuberculosis cases notified in
NSW from 2009-2011 indicated that 79.7% of cases were
immigrants born in tuberculosis endemic countries; drug
resistant disease was rare. [5]. The use of 12-loci MIRU
typing described the M. tuberculosis population structure,
but provided insufficient discrimination to confidently iden-
tify local transmission chains. The current study aimed to
examine temporal trends in the M. tuberculosis epidemi-
ology and drug resistance rates. In addition, we compared
the discriminatory power of 24- and 12-loci MIRU in a
setting where the majority of M. tuberculosis strains are
imported from Asia.
Methods
Study setting and design
We report data from ongoing prospective surveillance
conducted by the NSW MRL at the Institute of Clinical
Pathology and Medical Research (ICPMR) in Sydney,
Australia. It receives M. tuberculosis isolates from tuber-
culosis cases diagnosed throughout the state. New cul-
ture confirmed tuberculosis cases identified between
January 2010 and December 2012 were included in the
study. Basic patient demographic data including age,
gender, residential postcode and site of disease were re-
trieved from the ICPMR information system. The Inter-
national Classification of Disease (ICD-9) coding was
used to assess the site of disease, among those diagnosed
with tuberculosis (category 9) subcategory 010, 011
and 012 were classified as respiratory disease and all
other subcategories regarded as non-respiratory dis-
ease. Duplicate isolates and patients infected with
mycobacterial species other than M. tuberculosis com-
plex were excluded from the analysis.
Isolates
All M. tuberculosis isolates were identified by conven-
tional methods and their identity was confirmed by
high-performance liquid chromatography (HPLC) of
mycolic acids (Waters™ LS Module 1Plus, Milford, MA,
USA), DNA probes and in-house PCR, targeting the
16S-23S rRNA gene internal transcribed spacer region,
when necessary. Susceptibilities to isoniazid (INH) and
rifampicin (RIF), pyrazinamide and ethambutol were
tested at “breakpoint” concentrations using the BACTEC
MGIT™ 960 system (Becton Dickinson) according to
the manufacturer’s instructions. Isolates were considered
resistant to INH and RIF when they grew in the presence
of 0.4 mg/L and 0.1mg/L of drug, respectively.
Genotyping and mapping
Isolates were genotyped using 24-loci MIRU as previ-
ously described [8]. M. tuberculosis population structure
and drug resistance profiles were compared for the time
period covered by the current study (2010-2012) and a
previous assessment done from 2006-2008 [10]. For
cluster analysis, two or more strains with identical MIRU
profiles were considered a cluster. The recent transmis-
sion rate was calculated as follows [(number of clustered
isolates - number of clusters)/total number of cultured
isolates] [11]. M. tuberculosis lineage assignment was done
using the on-line MIRU-VNTRplus database (http://www.
miru-vntrplus.org). The isolates were assigned to global
lineages and sublineages: Lineage 1 – Indo-Oceanic
(East-African-Indian sublineage); Lineage 2 – East-Asian
(Beijing sublineage); Lineage 3 – East-African-Indian
(Delhi/Central Asian sublineage) and Lineage 4 – Euro-
American (Latin-American and Haarlem sublineages).
Tuberculosis cases were geomapped using their postcodes
of residence and the Australian Pathogen Intelligence
Community Space (APICS) online tool (www.abin.org.au);
11 cases belonging to the largest single cluster identified
by 24-loci MIRU typing were mapped.
Statistical analysis
Associations between M. tuberculosis lineage and patient
age, gender, main site of disease and drug resistance
were explored by χ2 and Fisher’s exact tests using SPSS
21.0 software (IBM, USA). A p-value of less than 0.05
was considered statistically significant. Ethics clearance
was provided by Human Research Ethics Committee of
the University of Sydney (project number 2013/126).
Results
A total of 1192 patients were identified with culture-
confirmed M. tuberculosis complex between January
2010 and December 2012; 1177 with M. tuberculosis, 1
with M. bovis and 14 with M. bovis BCG. (Figure 1) Of
those with M. tuberculosis, 1128 (95.8%) were successfully
strain typed and included in population structure compari-
sons and cluster analysis. Demographic analysis was re-
stricted to 1079 (91.7%) cases with complete MIRU typing,
DST results and relevant demographic data.
Patient demographics, site of disease, strain family and
drug resistance profiles are summarized in Table 1. Total
case numbers showed little variability, ranging from 351
to 371 between 2010 and 2012. Only 15 (1.4%) children
were diagnosed with culture-confirmed tuberculosis, repre-
senting a wide variety of lineages; East African Indian (EAI)
5, Latin American Mediterranean (LAM) 2, Beijing 1,
Delhi/CAS 1, Haarlem 1, and others 5. A large proportion
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of cases (270 or 25.0%) were older than 60 years of age. In
total 18 cases (1.7%) of multi-drug resistant (MDR) tuber-
culosis (MDRTB) were detected; 1 being extensively-drug
resistant (XDR). Beijing and EAI strain families were most
common, accounting for 27.6% and 28.5% of strains, re-
spectively. Beijing was the only strain family significantly
associated with respiratory disease and drug resistance
(p = 0.02 and p = 0.04, respectively; compared to all other
strains). Inversely EAI strain lineage was associated with
non-respiratory tuberculosis (p = 0.03) (Figure 2). Mean
patient age was significantly associated with lineage
(p < 0.001); Delhi/CAS with younger (37 years) and
Haarlem with older (57 years) mean age. Beijing family
strains were more prevalent among young adults (15-29
years) and the elderly (≥60 years) (p < 0.001) (Figure 3).
Recent trends in the M. tuberculosis population struc-
ture are documented in Table 2. Both surveys (the 2006-
2008 and 2010-2012) included more than 90% of all new
cases with culture-confirmed tuberculosis. The proportion
of Beijing strains remained stable (24.1% and 27.6%), but
EAI strains increased from 11.8% to 28.5%, rivaling Beijing
as the dominant strain family in the most populous state of
Australia. The relative number of Delhi/CAS strains also
doubled from 6.5% to 13.8%. Rates of drug resistance
remain similar across both time periods; 6.9% vs 6.8% iso-
niazid resistance and 1.1% vs 1.7% MDR resistance (resist-
ant to INH and RIF). No cases of RIF mono-resistance
were detected during the study period.
Among 1128 cases, 12-loci MIRU detected 572 differ-
ent profiles with 61.6% (695) of isolates grouped into
139 clusters. The improved resolution provided by 24-
loci MIRU detected 983 different profiles with 20.1%
(227) of isolates grouped into 82 clusters.(Table 3) The
decrease in clustering documented with 24- compared
to 12-loci MIRU was most pronounced for EAI and
Delhi/CAS strains; clustering rates reduced from 58.6%
to 13.6% and 43.7% to 7.6%, respectively. The calculated
transmission rate, comparing 24- to 12-loci MIRU, was
reduced from 49.3% to 12.8%. There was no evidence of
local transmission of MDRTB strains; MIRU-24 profiles
of all MDRTB strains were unique. With 12-loci MIRU
17/73 (23.3%) INH-monoresistant cases grouped into 2
clusters, but with 24-loci MIRU only a single 2-member
cluster (2/73; 2.7%) was detected.
Beijing family strains showed the higher clustering
rates; 80.6% with 12- and 40.5% with 24-loci MIRU
respectively. The most common 24-loci MIRU profile
belonged to a Beijing cluster with 11 members. Cases of
Figure 1 Flow diagram of new cases with culture-confirmed M. tuberculosis complex diagnosed in NSW. *Used for population structure
and clustering analysis (Table 3) **Used for demographic and drug resistance analysis (Tables 1 and 2) #Phenotypic drug susceptibility test
(routinely done for INH and RIF).
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tuberculosis associated with the cluster were widely dis-
persed within the greater Sydney area without evidence
of any social contact (see Additional file 1).
Recent report suggested that a subgroup of Beijing
family with 12-loci MIRU 223325173533 profile have
been associated with increased transmissibility and drug
resistance in China [12]. We have identified 94 isolates
with this profile; 35, 30 and 29 strains detected in 2010,
2011 and 2012, respectively and 11/94 (11.7%) strains












Figure 2 M. tuberculosis strain family and site of disease.
Table 1 Demographics, site of disease, strain family and drug resistance profile in new patients with culture–confirmed
tuberculosis diagnosed in New South Wales, Australia
Category Year Total
2010 2011 2012 n (%)
Gender
Male 219 (61.3) 219 (59.0) 188 (53.6) 626 (58.0)
Age group
<15 years 4 (1.1) 5 (1.3) 6 (1.7) 15 (1.4)
15-29 years 99 (27.7) 94 (25.3) 102 (29.1) 295 (27.3)
30-44 years 110 (30.8) 116 (31.3) 102 (29.1) 328 (30.4)
45-59 years 63 (17.6) 60 (16.2) 48 (13.7) 171 (15.8)
≥60 years 81 (22.7) 96 (25.9) 93 (26.5) 270 (25.0)
Site of disease
Respiratory 258 (72.3) 260 (70.1) 241 (68.7) 759 (70.3)
Non-respiratory 99 (27.7) 111 (29.9) 110 (31.3) 320 (29.7)
Strain family
Beijing 93 (26.1) 108 (29.1) 97 (27.6) 298 (27.6)
East African Indian 112 (31.4) 101 (27.2) 95 (27.1) 308 (28.5)
Delhi/CAS 47 (13.2) 53 (14.3) 49 (14.0) 149 (13.8)
LAM 25 (7.0) 14 (3.8) 22 (6.3) 61 (5.7)
Haarlem 13 (3.6) 21 (5.7) 24 (6.8) 58 (5.4)
Other 67 (18.8) 74 (19.9) 64 (18.2) 205 (19.0)
Drug resistance
Isoniazid mono-resistance 21 (5.9) 23 (6.2) 29 (8.3) 73 (6.8)
Multi- or extremely drug resistant (M/XDR) 7 (2.0) 6 (1.6) 5 (1.4) 18 (1.7)
Total 357 (100) 371 (100) 351 (100) 1079 (100)
Gurjav et al. BMC Infectious Diseases 2014, 14:455 Page 4 of 8
http://www.biomedcentral.com/1471-2334/14/455
Discussion
We found that Beijing and EAI strains accounted for
nearly 60% of all M. tuberculosis isolates identified dur-
ing the study period. While the relative frequency of in-
fections due to Beijing strains has remained stable since
2006 [10], the number of patients infected with EAI and
Delhi/CAS strains has doubled in recent years. The
dominance of these strain families and recent changes in
relative frequency likely reflect changes in immigration
patterns in Australia the last decades. Due to the geo-
ethnical restriction of major strain families, strain family
prevalence is greatly influenced by country of origin.
This has been observed in countries such as the USA,
the United Kingdom and Canada [13-15]. EAI strains
are most abundant in the Indian subcontinent and in
East Africa, whereas Beijing strains originated in Asia
and are most prevalent in countries such as China and
Vietnam [16]. During 2009 88% of tuberculosis cases
identified in Australia occurred in people born overseas,
with 38% of cases born in India and Vietnam [4], where
Delhi/CAS, EAI and Beijing are recognized as predominant
strain families [17,18]. Studies conducted in Cambodia,
Indonesia and Papua New Guinea, reported a high preva-
lence of the same strain families [19-21].
Interestingly, in our study Beijing strains were most
common in young adults (15-29 years of age) and in the
elderly (≥60 years of age). Its association with younger
age has been regarded as a marker of strain emergence
in Vietnam [18], but the age associations observed in NSW
likely reflect an immigrant cohort effect. The association
between Beijing strain family and respiratory tuberculosis
requires cautious interpretation, since it included pleural
tuberculosis and is not necessarily related to transmission
risk. Beijing family strains have been associated with drug
resistance in various parts of the world [22-24], although
this is not a consistent finding [25]. The number of cases of
MDRTB in our study was small and rates of drug resistant
disease unchanged since 2006, however, drug resistance
was found to be more common in Beijing strains. A retro-
spective study from Canada also demonstrated an increased
frequency of drug resistance among Beijing strains, but
found no correlation with the presence of lung cavities,
high bacillary loads or severe forms of disease [23]. In
Russia, drug resistant Beijing strains spread extensively
throughout the prison system [26]. Initial descriptions in-
volved modern Beijing strains, but it has now been recog-
nized that ancient (atypical) Beijing strains are associated
with clonal spread of extensive drug resistance in South Af-
rica and Japan [27,28]. Our research showed that the EAI
lineages trains were more common in patients with non-
respiratory tuberculosis. Similar findings have previously
been reported in the USA after adjusting for confounding
factors [29]. Studies have also suggested that EAI is less
transmissible and thereby less frequently clustered than




















Figure 3 Relative abundance of prevalent M. tuberculosis strain families in particular age groups.
Table 2 Changes in M. tuberculosis population structure
and drug resistance profiles in New South Wales,
Australia
Characteristic 2006-2008* 2010-2012** p-value
n (%) n (%)
Number of isolates included 855 (100) 1079 (100)
Strain family (%)
Beijing 206 (24.1) 298 (27.6) 0.58
East African Indian (EAI) 101 (11.8) 308 (28.5) <0.01
Delhi/CAS 55 (6.5) 149 (13.8) 0.13
Drug resistance (%)
Isoniazid mono-resistance 59 (6.9) 73 (6.8) 1
Multi-drug resistant (MDR)*** 9 (1.1) 18 (1.7) 0.56
Notes:
*MIRU-12 typing and spoligotyping.
**MIRU-24 typing.
***Single extensively drug resistant (XDR) case detected in 2010.
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EAI (13.6%) was three-times lower than that for Beijing
lineage strains (40.5%).
Traditional strain clustering indices provide an import-
ant marker of transmission within communities and
have been used to analyze transmission patterns and
guide public health intervention. However, its value may
be reduced in areas dominated by imported disease,
where identified clusters are less likely to be epidemiologi-
cally linked [31]. The problem can be more pronounced
when strain typing methods have sub-optimal discrimin-
atory power. Compared to 12-loci, 24-loci MIRU typing
provides enhanced resolution, but this remained sub-
optimal especially for Beijing strains, as reflected by the
high clustering rate (40.5%) and wide geographic dispersal
observed among the largest single cluster, without evidence
of epidemiological links. Studies from Asia and Russia have
emphasized high levels of genome homoplasy within the
Beijing strain family [32,33], and identified the need for
more accurate cluster differentiation. Analysis of an add-
itional 4 loci has been suggested to improve Beijing strain
family discrimination of standard MIRU-24 [34,35]. Sub-
optimal discrimination is an important limitation of
MIRU-24 in areas where Beijing family strains are com-
mon, since it limits the ability to identify transmission
chains and direct public health responses. High reso-
lution typing methods based on whole genome sequen-
cing showed the promise for more targeted public health
responses in non-endemic areas dominated by imported
disease [36].
Some limitations of our study should be acknowledged.
First, our dataset did not include all tuberculosis cases, al-
though the 1079 cases included in the study represent 71%
of tuberculosis notifications in NSW during the study
period. Second, since this was a laboratory-based study we
did not have access to detailed clinical or epidemiological
data. Third, some strain families eg. Euro-American line-
ages with unique 24-loci MIRU patterns could not be
clearly distinguished from the MIRU-VNTRplus database.
The previous study (2006-2008), to which our data was
compared, used a combination of 12-loci MIRU and spoli-
gotyping for strain family assignment, leading to some
minor discrepancies that had to be resolved. However, only
24 isolates were affected. Thus we believe that these limita-
tions would not have influenced the direction of our
conclusions or statistical significance of our findings. The
calculated transmission rate should be interpreted with cau-
tion, given the high proportion of Beijing isolates among
clustered strains (125/227; 55%) and the typing method
limitations discussed earlier. Geographic case distribution
and contact information suggests that the calculated trans-
mission rate could overestimate local transmission.
Conclusion
As in other low-incidence countries the M. tuberculosis
population structure in Australia is shaped by migrant
flows. Temporal dynamics were characterized by a relative
increase in Indo-Oceanic and EAI global lineages among
patients with culture-confirmed tuberculosis in New
South Wales, especially among young children. Standard
24-loci MIRU typing provided sub-optimal strain differen-
tiation and cluster identification. High resolution typing
methods are required for accurate transmission tracking,
especially of Beijing family strains, to help guide public
health responses.
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Table 3 Comparison of M. tuberculosis clustering based on MIRU-12 and MIRU-24 typing
Characteristic Dominant strain families Total
Beijing EAI** Delhi/CAS (N = 1128)
(N = 309) (N = 324) (N = 158)
MIRU number of loci* 12 24 12 24 12 24 12 24
Number of clusters 32 42 35 18 17 5 139 82
Number of clustered isolates# 249 125 190 44 69 12 695 227
% clustering 80.6 40.5 58.6 13.6 43.7 7.6 61.6 20.1
Average cluster size 8 3 5.4 2.4 4.1 2.8 5 2.8
Transmission rate (%)## 70.2 26.9 47.8 8.0 32.9 4.4 49.3 12.8
*MIRU - mycobacterial interspersed repetitive unit.
**EAI – East African Indian strain family (Lineage 3).
#Two or more strains with identical MIRU profiles were considered a cluster.
##Calculated as (number of clustered isolates - number of clusters)/total number of isolates.
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